These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 30868675)
21. VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling. Zhou Z; Zhou Q; Wu X; Xu S; Hu X; Tao X; Li B; Peng J; Li D; Shen L; Cao Y; Yang L Cancer Lett; 2020 Mar; 473():62-73. PubMed ID: 31904479 [TBL] [Abstract][Full Text] [Related]
22. Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells. Zhang D; Ding L; Li Y; Ren J; Shi G; Wang Y; Zhao S; Ni Y; Hou Y Sci Rep; 2017 Nov; 7(1):16231. PubMed ID: 29176691 [TBL] [Abstract][Full Text] [Related]
23. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer. Ham IH; Oh HJ; Jin H; Bae CA; Jeon SM; Choi KS; Son SY; Han SU; Brekken RA; Lee D; Hur H Mol Cancer; 2019 Mar; 18(1):68. PubMed ID: 30927911 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway. Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C Cell Biochem Funct; 2018 Jun; 36(4):194-202. PubMed ID: 29653464 [TBL] [Abstract][Full Text] [Related]
25. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway. Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867 [TBL] [Abstract][Full Text] [Related]
26. Cancer-Associated Fibroblasts Hinder Lung Squamous Cell Carcinoma Oxidative Stress-Induced Apoptosis via METTL3 Mediated m Li Y; Li X; Deng M; Ye C; Peng Y; Lu Y Oxid Med Cell Longev; 2022; 2022():4320809. PubMed ID: 36246404 [TBL] [Abstract][Full Text] [Related]
27. Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells. He J; Shi J; Zhang K; Xue J; Li J; Yang J; Chen J; Wei J; Ren H; Liu X Mol Med Rep; 2017 Apr; 15(4):1693-1701. PubMed ID: 28259951 [TBL] [Abstract][Full Text] [Related]
28. Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation. Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):748-756. PubMed ID: 29961813 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib. Tong M; Che N; Zhou L; Luk ST; Kau PW; Chai S; Ngan ES; Lo CM; Man K; Ding J; Lee TK; Ma S J Hepatol; 2018 Oct; 69(4):826-839. PubMed ID: 29885413 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression. Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979 [TBL] [Abstract][Full Text] [Related]
31. u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression. Ciavarella S; Laurenzana A; De Summa S; Pilato B; Chillà A; Lacalamita R; Minoia C; Margheri F; Iacobazzi A; Rana A; Merchionne F; Fibbi G; Del Rosso M; Guarini A; Tommasi S; Serratì S BMC Cancer; 2017 Mar; 17(1):215. PubMed ID: 28340565 [TBL] [Abstract][Full Text] [Related]
32. Sclareol ameliorated ERCC1-mediated cisplatin resistance in A549 human lung adenocarcinoma cells and a murine xenograft tumor model by suppressing AKT-GSK3β-AP1/Snail and JNK-AP1 pathways. Pan CH; Chen SY; Wang JY; Tsao SP; Huang HY; Wei-Chen Chiu P; Wu CH Chem Biol Interact; 2020 Dec; 332():109304. PubMed ID: 33164868 [TBL] [Abstract][Full Text] [Related]
33. Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform. Ying L; Zhu Z; Xu Z; He T; Li E; Guo Z; Liu F; Jiang C; Wang Q PLoS One; 2015; 10(6):e0129593. PubMed ID: 26115510 [TBL] [Abstract][Full Text] [Related]
34. Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion. Hao J; Zeltz C; Pintilie M; Li Q; Sakashita S; Wang T; Cabanero M; Martins-Filho SN; Wang DY; Pasko E; Venkat K; Joseph J; Raghavan V; Zhu CQ; Wang YH; Moghal N; Tsao MS; Navab R Neoplasia; 2019 May; 21(5):482-493. PubMed ID: 30978569 [TBL] [Abstract][Full Text] [Related]
35. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway. Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754 [TBL] [Abstract][Full Text] [Related]
36. Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway. Zhang Q; Yang J; Bai J; Ren J Cancer Sci; 2018 Apr; 109(4):944-955. PubMed ID: 29383798 [TBL] [Abstract][Full Text] [Related]
37. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts. Kong J; Tian H; Zhang F; Zhang Z; Li J; Liu X; Li X; Liu J; Li X; Jin D; Yang X; Sun B; Guo T; Luo Y; Lu Y; Lin B; Liu T Mol Cancer; 2019 Dec; 18(1):175. PubMed ID: 31796058 [TBL] [Abstract][Full Text] [Related]
38. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner. Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681 [TBL] [Abstract][Full Text] [Related]
39. Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance. Uchihara T; Miyake K; Yonemura A; Komohara Y; Itoyama R; Koiwa M; Yasuda T; Arima K; Harada K; Eto K; Hayashi H; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Yashiro M; Masuda M; Ajani JA; Tan P; Baba H; Ishimoto T Cancer Res; 2020 Aug; 80(16):3222-3235. PubMed ID: 32605995 [TBL] [Abstract][Full Text] [Related]
40. Dendrobine targeting JNK stress signaling to sensitize chemotoxicity of cisplatin against non-small cell lung cancer cells in vitro and in vivo. Song TH; Chen XX; Lee CK; Sze SC; Feng YB; Yang ZJ; Chen HY; Li ST; Zhang LY; Wei G; Shi J; Xu K; Ng TB; Zhu LL; Zhang KY Phytomedicine; 2019 Feb; 53():18-27. PubMed ID: 30668397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]